Shop by goal

Popular compounds

Research resources

KPV: Healing / Recovery research guide

Not medical advice. KPV is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

What KPV is

KPV is the three-amino-acid tail of α-melanocyte stimulating hormone that retains the full anti-inflammatory punch of the parent hormone without touching melanocortin receptors.

One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.

KPV anti-inflammatory tripeptide from α-MSH C-terminus inhibits NF-κB via importin-α3 competitive blockade, independent of melanocortin receptor signaling.

Research contexts

Peer-reviewed literature typically discusses KPV in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.

Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.

Typical study contexts

Rodent and cell models of tendon, muscle, ligament, or gut injury, scientists track repair markers, cell migration, and inflammatory readouts.

Wound-healing and angiogenesis assays where the question is how tissue responds after controlled damage.

Occasional case-style write-ups in research settings; these are not substitutes for clinical evidence.

Peer-reviewed preclinical work sometimes describes experiments that track whether competitively blocks importin-α3/p65RelA interaction, preventing NF-κB nuclear translocation and inflammatory gene transcription

Peer-reviewed preclinical work sometimes describes experiments that track whether suppresses production of TNF-α, IL-6, and IL-1β pro-inflammatory cytokines without melanocortin receptor activation

Peer-reviewed preclinical work sometimes describes experiments that track whether pepT1-mediated intestinal uptake provides targeted anti-inflammatory action in IBD and colitis models

Peer-reviewed preclinical work sometimes describes experiments that track whether retains full anti-inflammatory potency of parent α-MSH (13 aa) in a tripeptide fragment

Why Healing / Recovery research matters

Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.

Mechanisms (technical review)

Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.

Competitively blocks importin-α3/p65RelA interaction, preventing NF-κB nuclear translocation and inflammatory gene transcription

Suppresses production of TNF-α, IL-6, and IL-1β pro-inflammatory cytokines without melanocortin receptor activation

PepT1-mediated intestinal uptake provides targeted anti-inflammatory action in IBD and colitis models

Retains full anti-inflammatory potency of parent α-MSH (13 aa) in a tripeptide fragment

Reduces polymorphonuclear leukocyte migration in cutaneous and allergic inflammation models

Demonstrates efficacy in asthma, rheumatoid arthritis, ocular, and brain inflammation models

Lab handling & preparation

Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.

Research dosing context: Literature typically discusses 200-500 μg per day · Once or twice daily, subcutaneous injection or oral administration · MW 342.43 Da, extremely small peptide with favorable oral absorption profile. PepT1 transporter-mediated uptake in intestinal epithelium. Non-MCR mechanism confirmed: does not bind MC1,3,5R and does not compete with α-MSH. Minimal systemic immunosuppressive risk compared to broad-spectrum anti-inflammatory agents.

Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.

Common Questions People Are Asking

What is KPV and how does it work?

KPV is the C-terminal tripeptide (Lys-Pro-Val) of α-melanocyte stimulating hormone. It works by entering cells through the PepT1 di/tripeptide transporter, translocating to the nucleus, and competitively blocking the import of the NF-κB p65 subunit — shutting down the master switch for inflammatory gene expression. Crucially it does this without activating melanocortin receptors, so it carries α-MSH's anti-inflammatory activity in isolation.

Why does KPV have α-MSH's anti-inflammatory power without its pigmentation effect?

α-MSH produces pigmentation through melanocortin receptor activation at its N-terminal core (around His-Phe-Arg-Trp). KPV is just the C-terminal tail, which has no melanocortin receptor affinity but carries the non-MCR anti-inflammatory activity mediated by NF-κB blockade. Splitting the activities apart is the whole point of using the fragment.

What does the colitis research actually show?

In the landmark Dalmasso et al. study (Gastroenterology, 2008), oral KPV was transported into colonic cells via PepT1 and reduced both DSS- and TNBS-induced colitis in mice, lowering disease-activity and histological inflammation scores. Mechanistically it inhibited NF-κB and MAP-kinase signalling and reduced pro-inflammatory cytokine secretion in epithelial cells and macrophages. These are preclinical animal-model findings, not demonstrated human effects.

Is KPV primarily a gut peptide?

Not exclusively, but the PepT1 transporter is most abundant in the small intestine and colon, which gives KPV a natural bias toward gut-targeted effects. It has also been studied in cutaneous, ocular, respiratory, and joint inflammation models, so its anti-inflammatory mechanism is broadly relevant — gut targeting is just its most distinctive feature.

Can KPV be taken orally in research models?

Its small size and PepT1 uptake give KPV unusually favourable oral absorption characteristics for a peptide, and oral administration has been used in preclinical IBD models with measurable anti-inflammatory effect. Formal human oral pharmacokinetic data is limited, so published protocols also use parenteral delivery for consistency. KPV is supplied for laboratory research only.

How does KPV compare with BPC-157 for gut research?

Both are studied for gut protection but through different mechanisms. KPV is a direct anti-inflammatory: it blocks NF-κB to dampen the cytokine cascade and homes to inflamed tissue via PepT1. BPC-157 is a broader tissue-repair and cytoprotective peptide acting through VEGFR2/eNOS angiogenesis and growth-hormone-receptor pathways. Researchers studying inflammation specifically often choose KPV; those studying mucosal repair often choose BPC-157.

How should KPV be stored and handled?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1–6 °C and protect from light. The tripeptide is one of the smaller and more robust research peptides and tolerates standard handling, but avoid repeated freeze-thaw cycles of the reconstituted solution.

Is this page medical advice? Can I use KPV for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find KPV specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside KPV.

TB-500 - companion guide

BPC-157 - companion guide

AOD-9604 - companion guide

Thymosin Alpha-1 - companion guide

Scientific sources & further reading

Primary literature and registries for KPV, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on KPV

ClinicalTrials.gov: registered studies on KPV

KPV: Wikipedia

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: KPV Tripeptide, α-MSH(11-13), Alpha-MSH C-Terminal Fragment, Lys-Pro-Val, Anti-Inflammatory Tripeptide, α-Melanocyte-Stimulating Hormone Fragment

Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.